GPS driving: a digital biomarker for preclinical Alzheimer disease

BACKGROUND: Alzheimer disease (AD) is the most common cause of dementia. Preclinical AD is the period during which early AD brain changes are present but cognitive symptoms have not yet manifest. The presence of AD brain changes can be ascertained by molecular biomarkers obtained via imaging and lum...

Descripción completa

Detalles Bibliográficos
Autores principales: Bayat, Sayeh, Babulal, Ganesh M., Schindler, Suzanne E., Fagan, Anne M., Morris, John C., Mihailidis, Alex, Roe, Catherine M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8204509/
https://www.ncbi.nlm.nih.gov/pubmed/34127064
http://dx.doi.org/10.1186/s13195-021-00852-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8204509/
https://www.ncbi.nlm.nih.gov/pubmed/34127064
http://dx.doi.org/10.1186/s13195-021-00852-1

Ejemplares similares